Catalyst Wire Dossier Catalyst Wire Dossier

Anti-CD38 antibody

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Anti-CD38 antibody, covering 2025-02-21 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP) [Phase 2]

See pricing